A new study has shown that a new experimental drug developed by AstraZeneca delays the progress of ovarian cancer significantly.

Lead researcher Dr Jonathan Ledermann said that the drug will now undergo wider trials though he added that patients experienced side effects including nausea, fatigue, vomiting and anemia.
“A well-tolerated antitumor agent that could be used for months or perhaps years as maintenance therapy after standard chemotherapy could be a big step forward and ultimately extend survival”, Dr Ledermann added.
Source-Medindia